Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.810
+0.080 (4.62%)
At close: Jun 26, 2026, 4:00 PM EDT
1.830
+0.020 (1.10%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $42.7 million as of June 26, 2026. Its market cap has decreased by -41.63% in one year.
Market Cap
42.70M
Enterprise Value
18.58M
1-Year Change
-41.63%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $42.70M, a decrease of -79.55%. That is a compound annual growth rate of -29.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 42.70M | 22.30% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 46.69M |
| Radiopharm Theranostics | 46.59M |
| Eloxx Pharmaceuticals | 45.41M |
| CervoMed | 44.50M |
| RenovoRx | 44.06M |
| Estrella Immunopharma | 41.53M |
| INmune Bio | 41.21M |
| Tevogen Bio Holdings | 39.95M |